APA (7th ed.) Citation

M, A., S, C., H, M., J, G., ML, L., P, S., . . . E, Y. (2018). Correction to: Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer. Breast cancer research and treatment, 167(2), 605. https://doi.org/10.1007/s10549-017-4633-6

Chicago Style (17th ed.) Citation

M, Asaduzzaman, et al. "Correction to: Tumour Suppressor EP300, a Modulator of Paclitaxel Resistance and Stemness, Is Downregulated in Metaplastic Breast Cancer." Breast Cancer Research and Treatment 167, no. 2 (2018): 605. https://doi.org/10.1007/s10549-017-4633-6.

MLA (9th ed.) Citation

M, Asaduzzaman, et al. "Correction to: Tumour Suppressor EP300, a Modulator of Paclitaxel Resistance and Stemness, Is Downregulated in Metaplastic Breast Cancer." Breast Cancer Research and Treatment, vol. 167, no. 2, 2018, p. 605, https://doi.org/10.1007/s10549-017-4633-6.